Premium
AN INTERNATIONAL COMPARISON OF THE EFFICACY, COST AND MYELOTOXICITY OF FIRST‐LINE THERAPY FOR ADVANCED FOLLICULAR NON‐HODGKIN LYMPHOMA
Author(s) -
Kesavan M.,
Mcquillan A.D.,
Macdonald W.B.,
Turner J.H.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_121
Subject(s) - medicine , follicular lymphoma , rituximab , clinical trial , oncology , regimen , progression free survival , lymphoma , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom